Many patients with weak immune systems don't realize COVID-19 meds aren't as effective anymore

The medicine is called Evusheld, and its effectiveness is waning dramatically because new COVID-19 subvariants are taking center stage.

Related Keywords

White House ,District Of Columbia ,United States ,New York ,Mexico ,New Jersey ,Missouri ,University Of Rochester ,Americans ,S Shahzad Mustafa ,Robyn Brumble ,Janet Handal ,Brian Koffman ,Rochelle Walensky ,Ashish Jha ,Judy Salins ,Us Centers For Disease ,Twitter ,A Us Chamber ,Astrazeneca ,Facebook ,Medicaid Services ,Human Services ,Northwell Health ,Us Department Of Health ,Drug Administration ,Administration For Strategic Preparedness ,Cnn ,Office Of Intergovernmental ,University Of Rochester Medical College ,Immunocompromised Patient Advocacy Group She ,Transplant Recipients ,Disease Control ,Salins Now ,Rochester Medical College ,Strategic Preparedness ,External Affairs ,Covid Medicine ,Dnd ,Weakened Immune Systems ,